A generic competitor called Exela Pharma Sciences' patents on intravenous cysteine hydrochloride frivolous. Judge Maryellen Noreika called them valid and infringed.
August 19, 2022 at 12:25 PM
6 minute read
Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. Here’s what’s shaking this week.
• Exela Pharma Sciences will get more than three years out of its patents on injectable cysteine, thanks to a Fish & Richardson trial team.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
